Healthcare -
Biotechnology - NASDAQ - US
$ 9.33
2.08 %
$ 465 M
Market Cap
-2.55
P/E
MLYS - STOCK-BASED COMPENSATION
Stock-based Compensation MLYS - Mineralys Therapeutics, Inc.
11.3 M
LAST VALUE
399.14%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR